Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
0 competitors in Skin Diseases, Infectious
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Sivextro
Sivextro tablets are indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults, adolescents and children weighing at least 35 kg. Sivextro powder for concentrate for solution for infusion is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) from birth. Sivextro powder for oral suspension is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in patients from birth. Consideration should be given to official guidance on the appropriate use of antibacterial agents.
View on EMAUrinary Tract Infection
Hematoma
Parkinsons Disease (PD)
Acute Coronary Syndrome
Chronic Kidney Disease